Global Primary Antibiotic Resistance Rate of Helicobacter pylori in Recent 10 years: A Systematic Review and Meta‐Analysis
Helicobacter · 2024-05 · 29 (3)
DOI: 10.1111/hel.13103 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Helicobacter, online erschienen am 19.06.2024. Verfasst von Yanhui Yu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Dongzhimen Hospital (Dongcheng Campus), Beijing University of Chinese Medicine, Beijing, China. Hauptthemen laut MEDLINE: Helicobacter pylori, Helicobacter Infections, Anti-Bacterial Agents, Drug Resistance, Bacterial. Die Arbeit wurde bisher 115-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Clinical Research and Achievement Transformation Ability Improvement Pilot Project of Dongzhimen Hospital, Beijing University of Chinese Medicine.
Abstract (Originalsprache)
Introduction
Due to irregular antibiotic use, the rate of antibiotic resistance to Helicobacter pylori ( H. pylori ) is increasing and varies from region to region. Therefore, for the purpose of further clarifying the changes in antibiotic resistance rates nowadays, we conducted a systematic review and meta‐analysis to update and assess the 10‐year trend of primary H. pylori antibiotic resistance rate to the commonly prescribed antibiotics worldwide. Materials and Methods According to the PRISMA statement, we systematically searched electronic databases for studies that assessed rates of H. pylori resistance to clarithromycin, metronidazole, levofloxacin, amoxicillin, or tetracycline published from 2013 to 2023. AHRQ was adopted to estimate methodological quality and publication bias in the included studies, and statistical analysis was performed using Stata 17.0.
Results
We identified 163 studies, comprising 47,002 isolates from 36 countries. The meta‐analysis showed that the primary antibiotic resistance rate of H. pylori varied widely among antibiotics. Subgroup analysis showed higher rates of antibiotic resistance in the adult population than in children, and a general trend of increased resistance was observed from 2013 to 2023. There was considerable heterogeneity ( I 2 > 75%) among all analyses, which may be due to high variability in resistance rates across the global regions.
Conclusions
Resistance of H. pylori to antibiotics has reached alarming levels worldwide, which has a great effect on the efficacy of treatment. Local surveillance networks are required to select appropriate eradication regimens for each region.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Dongzhimen Hospital (Dongcheng Campus), Beijing University of Chinese Medicine, Beijing, China.
- Department of Gastroenterology, Dongzhimen Hospital (Tongzhou Campus), Beijing University of Chinese Medicine, Beijing, China.
Förderung
- Clinical Research and Achievement Transformation Ability Improvement Pilot Project of Dongzhimen Hospital, Beijing University of Chinese Medicine
Zitieren
APA
Yu, Y., Xue, J., Lin, F., Liu, D., Zhang, W., Ru, S., & Jiang, F. (2024). Global Primary Antibiotic Resistance Rate of Helicobacter pylori in Recent 10 years: A Systematic Review and Meta‐Analysis. Helicobacter, 29(3). https://doi.org/10.1111/hel.13103
Vancouver
Yu Y, Xue J, Lin F, Liu D, Zhang W, Ru S, et al. Global Primary Antibiotic Resistance Rate of Helicobacter pylori in Recent 10 years: A Systematic Review and Meta‐Analysis. Helicobacter. 2024;29(3). doi:10.1111/hel.13103
BibTeX
@article{Yu2024,
author = {Yu, Yanhui and Xue, Jing and Lin, Fangbing and Liu, Daming and Zhang, Wen and Ru, Shuying and Jiang, Feng},
title = {Global Primary Antibiotic Resistance Rate of Helicobacter pylori in Recent 10 years: A Systematic Review and Meta‐Analysis},
journal = {Helicobacter},
year = {2024},
volume = {29},
number = {3},
doi = {10.1111/hel.13103}
}
EUVIMED